Titan Pharmaceuticals, Inc.
 (TTNP)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Nov. 16, 2015, 7:27 AM
    • Titan Pharmaceuticals (TTNP -0.6%) Q3 results: Revenues: $0; R&D Expense: $1M (+25.0%); SG&A: $0.8M (-11.1%); Net Loss: ($1.8M) (-357.1%); Loss Per Share: ($0.09) (-80.0%); Quick Assets: $9.7M (-37.4%).
    • No guidance given.
    | Nov. 16, 2015, 7:27 AM
  • Nov. 16, 2015, 7:03 AM
    • Titan Pharmaceuticals (NASDAQ:TTNP): Q3 EPS of -$0.09 beats by $0.02.
    | Nov. 16, 2015, 7:03 AM | 1 Comment
  • Nov. 13, 2014, 10:38 AM
    • Titan Pharmaceuticals (OTCQB:TTNP): Q3 EPS of -$0.01 in-line.
    • Revenue of $0.9M (-59.1% Y/Y) in-line.
    | Nov. 13, 2014, 10:38 AM
  • Nov. 7, 2014, 9:12 AM
    • Titan Pharmaceuticals (OTCQB:TTNP) will report Q3 results on the morning of November 14. The conference call will begin at 8:00 am PT/11:00 am ET.
    • Consensus view is a loss of ($0.01) per share on revenues of $910K.
    | Nov. 7, 2014, 9:12 AM
  • Aug. 13, 2014, 8:17 AM
    • Titan Pharmaceuticals (OTCQB:TTNP -1.4%) Q2 results: Revenues: $0.9M (-58.6%); Operating Expenses: $1.5M (-41.3%); Net Loss: ($0.8M) (-116.6%); Loss Per Share: ($0.01); Quick Assets: $8.9M (-25.0%).
    • No financial guidance given.
    | Aug. 13, 2014, 8:17 AM
Company Description
Titan Pharmaceuticals Inc is a specialty biopharmaceutical company developing proprietary therapeutics for the treatment of serious medical disorders.
Sector: Healthcare
Industry: Biotechnology
Country: United States